NHS Family Planning Act

Next on Editorial Spotlight: The Reproductive Health Act - Opinion

2009 Erin Gainer, formerly Executive Director of R & D, is appointed CEO. André Ulmann, the founder, became Chairman of the Supervisory Board. Foundation of the subsidiary British, Italian and Spanish based respectively in London, Rome and Madrid.

HRA Pharma gets European Marketing Authorization for ellaOne ® (ulipristal acetate).

2008

Presentation to the EMEA for the application for registration ellaOne ®.

2007 License agreement and development dell'ulipristal acetate in benign gynecological diseases with the Swiss company PregLem. 2006

Creation and launch of the "Mona Lisa Afrique" to provide free education, health education and IUD health personnel in many countries in West Africa.

Research and development agreement with the U.S. National Institute of Child Health and Human Develpment for the development of Mifedren ® (HRA 052015) in Cushing's syndrome secondary to ectopic ACTH secretion (a rare disease).

Start of Phase III studies ella ® / ellaOne ®, ulipristal acetate), a new generation emergency contraceptive, in collaboration with the Planned Parenthood Federation of America and the NHS Family Planning in Britain.

2005

Acquisition of Celogos, a biotechnology company focused on cellular therapies.

2004

Coinciding with the launch of Lysodren, HRA Pharma launches also Lysosafe, a free service for monitoring therapeutic blood concentration of the drug, designed to help clinicians to optimize the dose of Lysodren ®.

Start of the project in collaboration with the Population Council to develop a new delivery system dell'ulipristal locally to use as a method of contraception continues non-estrogenic, and with the Department of Obstetrics and Gynecology at the Kobe University Graduate School of Medicine on dell'ulipristal mechanism of action in the treatment of uterine fibroids.

2003 2002

Lysodren ® gets the Orphan Drug Designation in Europe for the symptomatic treatment of adrenal carcinoma in advanced.

Partnership with the Collaborative Group for Adrenocortical Carcinoma Therapy to fund the study FIRM-ACT (First International Randomized Trial in Metastatic Adrenocortical Cancer Treatment), the largest study ever carried out in this rare disease.

2001 Collaboration agreement with the U.S. National Institute of Child Health and Human Development for the clinical development of active CDB-2914 (ulipristal acetate) in various indications in the context of reproduction.

Saint Joseph Communications Life-Giving Love
Book (Saint Joseph Communications)
2008-05-22 23:07:33 by phylum

This is page 2 of 2 pages of christer stuff.

Isn't it amazing?
(Publisher of Music, Worship Materials & Books...the music of Mass)
(Pop Rock Music with a message of Catholicism)
(One More SoulÖFostering Godís plan for love, chastity, marriage, sex and children. Natural Family Planning.)
(Scriptural origins of the Rosary)
(Books & Audio by Boston College Professor of Philosophy)
(Pioneer Total Abstinence Assoc

You might also like:

Cloud Atlas - TV Spot 6
Cloud Atlas - TV Spot 6

UN to provide family planning 'services' in eight African countries  — Catholic Online
Evidence suggests that better educated women contribute much more to economies and plan families better than those lacking education. All of this is possible using existing monies, educational infrastructure, and natural family planning methods.

Related posts: